FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to a heterocyclic compound of the formula given below, where R1 is hydrogen or halogen; R2, R3, R4 are hydrogen or halogen, with the exception of benzyl 2-((2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-oxoquinazoline-3(4H)-yl)oxy)acetate, capable of inducing ferroptosis in metastatic melanoma and colon cancer cells.
EFFECT: technical result is obtaining novel quinazoline derivatives having useful biological properties.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| HYDROXAMIC ACIDS, 4-AMINOQUINAZOLINE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802463C1 |
| INDOLOCARBAZOLE DERIVATIVE BLOCKING TUMOUR VASCULOGENIC MIMICRY | 2014 |
|
RU2557554C1 |
| CHEMICAL COMPOUNDS-759 | 2008 |
|
RU2481348C2 |
| QUINAZOLINE DERIVATIVES | 2015 |
|
RU2704125C2 |
| HYDROXAMIC ACIDS, DERIVATIVES OF 4-AMINOQUINAZOLINE-7-CARBOXYLIC ACID AS INHIBITORS OF HISTONE DEACETYLASE, AND METHOD FOR SYNTHESIS THEREOF | 2021 |
|
RU2779981C1 |
| HETEROYRYL PYRIDONES AND AZAPIRIDONS WITH ELECTROPHILIC FUNCTIONALITY | 2014 |
|
RU2646758C2 |
| SUBSTITUTED 2-METHYLIDEN-5-(PHENYLAMINO)-2,3-DIHYDROTIOPHEN-3-ONE FOR TREATMENT OF LEUKEMIAS WITH TRANSLOCATIONS OF MLL-GENE AND OTHER ONCOLOGICAL DISEASES | 2017 |
|
RU2656603C1 |
| COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
| APPLICATION OF TRIINDOLYL METHANE DERIVATIVES AS ANTICANCER DRUGS | 2010 |
|
RU2454232C2 |
| DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
